Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avantor, Inc. Common Stock (NY:AVTR)

11.68 -0.14 (-1.18%)
Official Closing Price Updated: 6:30 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avantor, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Securities Fraud Investigation Into Avantor, Inc. (AVTR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
Avantor, Inc. (AVTR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
Earnings Scheduled For October 29, 2025
 
Via Benzinga
Avantor's Earnings Outlook
 
Via Benzinga
AVANTOR, INC. (NYSE: AVTR) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Avantor, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Avantor, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AVTR
From The Rosen Law Firm PA
Via GlobeNewswire
AVTR INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Avantor, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
AVANTOR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Avantor, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Avantor, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – AVTR
From DJS Law Group
Via Business Wire
AVTR Investors Have Opportunity to Lead Avantor, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Avantor (AVTR) Stock Trades Up, Here Is Why
Shares of life sciences company Avantor (NYSE:AVTR) jumped 4.8% in the afternoon session after a director purchased a significant amount of company stock, signaling strong insider confidence. 
Via StockStory
AVTR Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Avantor, Inc.
From Robbins LLP
Via GlobeNewswire
Rosen Law Firm Urges Avantor, Inc. (NYSE: AVTR) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From Rosen Law Firm
Via Business Wire
Securities Fraud Investigation Into Avantor, Inc. (AVTR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); DexCom, Inc. (NASDAQ: DXCM); Humana Inc. (NYSE: HUM); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
AVANTOR, INC. (NYSE: AVTR) INVESTOR ALERT Investors With Large Losses in Avantor, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
1 Healthcare Stock with Impressive Fundamentals and 2 We Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Stocks
AVTR DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor
From Faruqi & Faruqi, LLP
Via Business Wire
Avantor, Inc. (AVTR) Investors: Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against Avantor, Inc. and Encourages Investors With Substantial Losses to Contact the Firm
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
AVTR Q3 Deep Dive: Strategic Overhaul Launched Amid Margin and Execution Challenges
Life sciences company Avantor (NYSE:AVTR) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 5.3% year on year to $1.62 billion. Its non-GAAP profit of $0.22 per share was... 
Via StockStory
Topics Economy
Stocks Slide As Powell Cools Rate-Cut Hopes: These 15 Stocks Are Feeling The Pinch
Stocks fell as Fed Chair Powell warned a December rate cut is uncertain, citing data gaps and policy division. 
Via Benzinga
Topics Economy
Avantor Plummets 17.4% as Disappointing Q3 Results and Impairment Charge Rock Investor Confidence
Avantor (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied... 
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
Why Avantor (AVTR) Shares Are Trading Lower Today
Shares of life sciences company Avantor (NYSE:AVTR) fell 17.4% in the afternoon session after the company reported disappointing third-quarter 2025 results that missed revenue expectations and included... 
Via StockStory
Topics Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Avantor Struggles With Soft Demand But Backs Long-Term Value Through Buyback
Avantor stock fell after Q3 earnings and revenue missed estimates, leading the company to cut 2025 guidance but approve a $500 million buyback. 
Via Benzinga
Avantor Inc (NYSE:AVTR) Stock Plummets 17% After Q3 Revenue Miss
Avantor's Q3 2025 results missed revenue expectations, causing a sharp stock drop. While earnings per share met targets, sales fell 5.3% year-over-year. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Avantor (NYSE:AVTR) Misses Q3 Sales Expectations, Stock Drops 17.9%
Life sciences company Avantor (NYSE:AVTR) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 5.3% year on year to $1.62 billion. Its non-GAAP profit of $0.22 per share was... 
Via StockStory
Earnings To Watch: Avantor (AVTR) Reports Q3 Results Tomorrow
Life sciences company Avantor (NYSE:AVTR) will be announcing earnings results this Wednesday before market open. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.